Roivant Sciences Ltd

Company Snapshot
50 Broadway
London, SW1H 0BD
United Kingdom
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 908
https://www.roivant.com
Please select from the dropdown
  1. Executive Compensation
  2. > Roivant Sciences Ltd
Company Financials

2022
2023
2024
Gross Profit
$46,320,000
$48,152,000
$109,235,000
Operating Income
-$1,211,748,000
-$1,077,569,000
-$1,079,944,000
Net Income
-$845,262,000
-$1,009,030,000
$4,348,926,000
2022
Gross Profit
$46,320,000
Operating Income
-$1,211,748,000
Net Income
-$845,262,000
2023
Gross Profit
$48,152,000
Operating Income
-$1,077,569,000
Net Income
-$1,009,030,000
2024
Gross Profit
$109,235,000
Operating Income
-$1,079,944,000
Net Income
$4,348,926,000
The above data on Roivant Sciences Ltd came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Meghan Fitzgerald
Independent Director
$51,684
$889,993
$0
$941,677
Meghan Fitzgerald
$941,677
Independent Director
Mayukh Sukhatme
President, Chief Investment Officer and Director
$0
$0
$574,560
$574,560
Mayukh Sukhatme
$574,560
President, Chief Investment Officer and Director
Ilan Oren
Chairman of the Board
$94,250
$394,244
$0
$488,494
Ilan Oren
$488,494
Chairman of the Board
James Momtazee
Independent Director
$65,000
$394,244
$0
$459,244
James Momtazee
$459,244
Independent Director
Daniel Gold
Independent Director
$55,000
$394,244
$0
$449,244
Daniel Gold
$449,244
Independent Director
Roivant Sciences Ltd listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2024. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us